Literature DB >> 9952091

Effect of Staphylococcus aureus bacteria and bacterial toxins on meningeal permeability in vitro.

W C Ummenhofer1, A E Stapleton, C M Bernards.   

Abstract

BACKGROUND AND OBJECTIVES: Epidural catheterization is associated with a significant bacterial colonization rate and occasionally frank infection. During epidural space infection, decreased analgesia despite increased epidural opioid doses has been described. One possible explanation for this observation is that bacterial infection decreases meningeal permeability. The purpose of the study was to determine whether Staphylococcus aureus bacteria, the most common organism causing epidural space infection, or S. aureus toxins alter meningeal permeability.
METHODS: Spinal meninges of M. nemestrina monkeys were mounted in a previously established in vitro diffusion cell model and exposed to S. aureus toxins A, B, and F. Simultaneous transmeningeal fluxes of mannitol and sufentanil were measured before and after toxin exposure and compared to controls. In a second series of experiments, diffusion cells were inoculated with live S. aureus bacteria in suspension and the permeability of sufentanil was investigated.
RESULTS: Staphylococcus aureus toxin-A increased the transmeningeal flux of mannitol but not sufentanil. Toxins B and F did not alter the meningeal permeability of either drug. Inoculation with live S. aureus bacteria increased the transmeningeal flux of sufentanil by 115+/-21% (P = .032).
CONCLUSIONS: These data demonstrate that S. aureus alpha-toxin and live S. aureus bacteria can increase meningeal permeability. Thus, clinical observations of decreased epidural analgesia in the face of bacterial infection cannot be explained by decreased meningeal permeability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952091     DOI: 10.1016/s1098-7339(99)90161-x

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  1 in total

1.  Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques.

Authors:  Arundhathi Venkatasubramaniam; Grant Liao; Eunice Cho; Rajan P Adhikari; Tom Kort; Frederick W Holtsberg; Karen E Elsass; Dean J Kobs; Thomas L Rudge; Keith D Kauffman; Nickiana E Lora; Daniel L Barber; M Javad Aman; Hatice Karauzum
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.